TWST ▲ +5.7% - Twist Bioscience Corporation $TWST - Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery Twist Bioscience rose 5.7% after announcing it will join Eli Lilly's TuneLab program to support antibody drug discovery efforts. The partnership validates Twist's synthetic biology platform as a tool for accelerating pharmaceutical development, which likely drove investor optimism about near-term revenue opportunities and the company's competitive positioning in drug discovery services. 16-SEP-2026 08:07 AM ET